A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia

NCT03381833 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
84
Enrollment
INDUSTRY
Sponsor class

Stopped Terminated early for lack of efficacy as determined by interim endpoint analyses

Conditions

Interventions

Sponsor

La Jolla Pharmaceutical Company